Breaking News Instant updates and real-time market news.

EIDX

Eidos Therapeutics

$13.24

0.06 (0.46%)

16:27
11/06/18
11/06
16:27
11/06/18
16:27

Eidos Therapeutics reports Q3 EPS (29c), consensus (27c)

Cash and cash equivalents totaled $166.6 million at September 30, 2018 compared with $5.5 million at December 31, 2017."We are working to advance the AG10 clinical development program," said Neil Kumar PhD, chief executive officer of Eidos. "The Phase 1 data demonstrated that AG10 was well tolerated at blood concentrations resulting in near-complete TTR stabilization in healthy volunteers. We are announcing the results from the Phase 2 study in ATTR cardiomyopathy patients at the 2018 American Heart Association Annual Scientific Sessions on November 10, 2018."

  • 10

    Nov

  • 12

    Nov

  • 27

    Nov

EIDX Eidos Therapeutics
$13.24

0.06 (0.46%)

10/31/18
10/31/18
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. CVR Energy (CVI) initiated with a Buy at Citi. 2. Cheniere Energy (LNG) reinstated with an Overweight at JPMorgan. 3. Eidos Therapeutics (EIDX) initiated with a Buy at Roth Capital. 4. NV5 Global (NVEE) and GSE Systems (GVP) were initiated with a Buy at Maxim. 5. Nexa Resources (NEXA) initiated with an Outperform at National Bank. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/31/18
ROTH
10/31/18
INITIATION
Target $28
ROTH
Buy
Eidos Therapeutics initiated with a Buy at Roth Capital
Roth Capital analyst Yasmeen Rahimi started Eidos Therapeutics with a Buy rating and $28 price target. The analyst notes that the company's Phase 2 results are anticipated at the AHA meeting on November 10, and views AG10 as a best-in-class transthyretin stabilizer for treatment of ATTR-CM.
08/27/18
JPMS
08/27/18
NO CHANGE
JPMS
Overweight
JPMorgan views Eidos Therapeutics selloff on Pfizer data as overdone
JPMorgan analyst Anupam Rama views this morning's selloff in shares of Eidos Therapeutics (EIDX) following the data from Pfizer (PFE) as overdone. The stock in early trading is down 33%, or $6.65, to $13.58. The Tafamidis Phase 3 Transthyretin Cardiomyopathy study from Pfizer "leaves plenty of room for mortality improvement" for Eidos Therapeutics' AG10, Rama tells investors in a research note. He believes the weakness in Eidos is overdone based on the totality of the data presented at the ESC Congress and in the New England Journal of Medicine. Eidos has "plenty of catalysts on the horizon" that can help validate AG10, Rama contends. The analyst keeps an Overweight rating on the shares.
08/27/18
JPMS
08/27/18
NO CHANGE
JPMS
Eidos Therapeutics selloff today overdone, says JPMorgan
JPMorgan analyst Anupam Rama views this morning's selloff in shares of Eidos Therapeutics (EIDX) following the data from Pfizer (PFE) as overdone. The stock in early trading is down 33%, or $6.65, to $13.58.

TODAY'S FREE FLY STORIES

VZ

Verizon

$60.00

0.91 (1.54%)

13:56
11/16/18
11/16
13:56
11/16/18
13:56
Hot Stocks
Verizon acquires Software Defined Perimeter assets from Vidder »

Verizon has acquired the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

FB

Facebook

$139.00

-4.86 (-3.38%)

, SNAP

Snap

$6.33

-0.5 (-7.32%)

13:54
11/16/18
11/16
13:54
11/16/18
13:54
OnTheFly
#SocialStocks: Facebook's NY Times Trouble, Snap subpoenaed »

Welcome to…

FB

Facebook

$139.00

-4.86 (-3.38%)

SNAP

Snap

$6.33

-0.5 (-7.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 28

    Nov

CTSH

Cognizant

$70.11

1.44 (2.10%)

13:47
11/16/18
11/16
13:47
11/16/18
13:47
Hot Stocks
Cognizant sets mid-term goal of constant currency revenue CAGR of 7%-11% »

In investor day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

  • 26

    Nov

  • 02

    Dec

NAK

Northern Dynasty

$0.69

0.024 (3.59%)

13:41
11/16/18
11/16
13:41
11/16/18
13:41
Upgrade
Northern Dynasty rating change  »

Northern Dynasty upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLF

Financial Select Sector

$26.78

0.03 (0.11%)

13:40
11/16/18
11/16
13:40
11/16/18
13:40
Options
Size strangle in SPDR Financials »

Size strangle in SPDR…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:35
11/16/18
11/16
13:35
11/16/18
13:35
General news
Fedspeak will be very limited next week »

Fedspeak will be very…

LVS

Las Vegas Sands

$53.63

-0.11 (-0.20%)

13:25
11/16/18
11/16
13:25
11/16/18
13:25
Options
Las Vegas Sands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTWS

Connecticut Water

$69.67

-0.08 (-0.11%)

, SJW

SJW Corp.

$64.12

-0.32 (-0.50%)

13:25
11/16/18
11/16
13:25
11/16/18
13:25
Conference/Events
Connecticut Water to host special shareholder meeting »

Special Shareholder…

CTWS

Connecticut Water

$69.67

-0.08 (-0.11%)

SJW

SJW Corp.

$64.12

-0.32 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Nov

GOOG

Alphabet

$1,060.06

-4.68 (-0.44%)

, GOOGL

Alphabet Class A

$1,064.87

-6.35 (-0.59%)

13:18
11/16/18
11/16
13:18
11/16/18
13:18
Periodicals
Diane Greene confirms Thomas Kurian to become Google Cloud CEO »

Diane Greene, the CEO of…

GOOG

Alphabet

$1,060.06

-4.68 (-0.44%)

GOOGL

Alphabet Class A

$1,064.87

-6.35 (-0.59%)

ORCL

Oracle

$51.20

0.56 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
11/16/18
11/16
13:17
11/16/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
11/16/18
11/16
13:16
11/16/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$273.80

0.96 (0.35%)

13:12
11/16/18
11/16
13:12
11/16/18
13:12
Periodicals
White House says Trump just expressing optimism on trade, CNBC reports »

CNBC's Eamon Javers…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$273.80

0.96 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$273.79

0.95 (0.35%)

13:10
11/16/18
11/16
13:10
11/16/18
13:10
Periodicals
White House tells CNBC not to read too much into Trump's trade comments »

Immediately following…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$273.79

0.95 (0.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:09
11/16/18
11/16
13:09
11/16/18
13:09
General news
Baker-Hughes Rig Count N. Amer. data reported »

Week of 11/16…

BHGE

Baker Hughes

$23.40

0.11 (0.47%)

13:05
11/16/18
11/16
13:05
11/16/18
13:05
Hot Stocks
Baker Hughes reports U.S. rig count up 1 to 1,082 rigs »

Baker Hughes reports that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 14

    Nov

ECA

Encana

$7.56

-0.19 (-2.45%)

13:05
11/16/18
11/16
13:05
11/16/18
13:05
Options
Encana call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYRS

Syros Pharmaceuticals

$8.03

0.16 (2.03%)

13:00
11/16/18
11/16
13:00
11/16/18
13:00
Recommendations
Syros Pharmaceuticals analyst commentary  »

Syros Phase I dose…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 01

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$273.77

0.93 (0.34%)

12:54
11/16/18
11/16
12:54
11/16/18
12:54
General news
Trump says China 'wants to make a deal' on trade »

President Trump said in…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$273.77

0.93 (0.34%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PYPL

PayPal

$85.27

-1.48 (-1.71%)

12:50
11/16/18
11/16
12:50
11/16/18
12:50
Options
Notable call writing in Paypal as shares drop 2% »

Notable call writing in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 26

    Nov

  • 18

    Dec

GOOG

Alphabet

$1,051.92

-12.82 (-1.20%)

, GOOGL

Alphabet Class A

$1,057.14

-14.08 (-1.31%)

12:49
11/16/18
11/16
12:49
11/16/18
12:49
Periodicals
Google Cloud CEO to be replaced by former Oracle executive, CNBC reports »

Google (GOOG, GOOGL)…

GOOG

Alphabet

$1,051.92

-12.82 (-1.20%)

GOOGL

Alphabet Class A

$1,057.14

-14.08 (-1.31%)

ORCL

Oracle

$51.16

0.52 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 05

    Dec

  • 06

    Dec

  • 03

    Mar

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.08

-0.76 (-0.28%)

12:45
11/16/18
11/16
12:45
11/16/18
12:45
General news
Markets bounce higher after Trump comments on China trade talks »

The markets moved higher…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.08

-0.76 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
11/16/18
11/16
12:45
11/16/18
12:45
General news
Breaking General news story  »

Week of 11/16…

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.55

-0.29 (-0.11%)

12:40
11/16/18
11/16
12:40
11/16/18
12:40
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Trump says would like to…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.55

-0.29 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$272.55

-0.29 (-0.11%)

12:40
11/16/18
11/16
12:40
11/16/18
12:40
General news
Breaking General news story on S&P 500, SPDR S&P 500 ETF Trust »

Trump says does not want…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$272.55

-0.29 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IQ

iQIYI

$20.54

-0.53 (-2.52%)

12:40
11/16/18
11/16
12:40
11/16/18
12:40
Options
4K Jun 22.5 calls on iQiyi trade $3.40 »

4K Jun 22.5 calls on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.